WASHINGTON, D.C. (LOOTPRESS) — A nationwide recall has been issued for certain batches of clonazepam, a commonly prescribed medication used to treat anxiety, panic disorders, and seizures. The recall was initiated after the discovery of potential safety issues, prompting immediate action to safeguard public health.
Reason for the Recall
The recall, announced on November 16, 2024, involves multiple lots of clonazepam tablets. According to the U.S. Food and Drug Administration (FDA), the affected batches may contain inaccurate dosages or potential contaminants, which could pose risks to patients. Underdosing may lead to ineffective treatment of anxiety or seizures, while overdosing could increase the likelihood of serious side effects, including drowsiness, respiratory depression, or even overdose in severe cases.
Details of Affected Products
The recall applies to clonazepam tablets manufactured by Endo and distributed nationwide. Specific details, including lot numbers, expiration dates, and packaging information, have been provided on the FDA’s website to assist patients and healthcare providers in identifying affected products.
What to Do If You Are Affected
Patients currently taking clonazepam are urged to check their medication bottles for lot numbers and compare them against the recall list.
- Stop using affected medication immediately.
- Contact your healthcare provider to discuss alternative treatment options or to obtain a replacement prescription.
- Return recalled medications to your pharmacy or disposal site in accordance with FDA guidelines.
The FDA emphasizes that patients should not abruptly stop taking clonazepam without consulting a healthcare professional, as doing so could result in withdrawal symptoms or a resurgence of the underlying condition.
Company Statement
The manufacturer of the recalled clonazepam has issued an apology to patients and healthcare providers, stating, “We are committed to resolving this issue promptly and ensuring the safety and efficacy of our medications. Our team is working closely with the FDA to investigate the cause and prevent future occurrences.”
Public Health Implications
Clonazepam is widely used across the U.S., and the recall is expected to affect thousands of patients. The FDA and manufacturers are urging the public to report any adverse reactions or quality concerns to the FDA’s MedWatch Adverse Event Reporting Program online at FDA MedWatch or by phone at 1-800-FDA-1088.
Stay Informed
For the latest updates on the clonazepam recall and for a full list of affected lot numbers, visit the official FDA recall page or consult your pharmacist or healthcare provider.
